Gainers
- Fulcrum Therapeutics FULC shares rose 138.61% to $19.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 65.1 million shares, making up 36571.04% of its average full-day volume over the last 100 days. The company's market cap stands at $649.5 million. As per the press release, Q2 earnings came out today.
- Allied Healthcare Prods AHPI stock moved upwards by 25.69% to $12.72. Allied Healthcare Prods's stock is trading at a volume of 27.6 million shares as of 12:30 EST. This is 359.47% of its average full-day volume over the last 100 days. The company's market cap stands at $51.0 million.
- Exagen XGN stock rose 24.87% to $12.8. As of 12:30 EST, Exagen's stock is trading at a volume of 332.5K, which is 540.71% of its average full-day volume over the last 100 days. The company's market cap stands at $216.6 million. As per the news, the Q2 earnings report came out yesterday.
- Arcturus Therapeutics ARCT stock increased by 17.95% to $56.9. Trading volume for this security as of 12:30 EST is 3.7 million, which is 494.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion. The company's, Q2 earnings came out yesterday.
- Novavax NVAX shares rose 15.65% to $246.5. As of 12:30 EST, this security is trading at a volume of 8.8 million shares, making up 196.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.3 billion. The company's, Q2 earnings came out 3 days ago.
- Xenetic Biosciences XBIO stock rose 13.87% to $3.94. Trading volume for Xenetic Biosciences's stock is 4.5 million as of 12:30 EST. This is 50.87% of its average full-day volume over the last 100 days. The company's market cap stands at $38.2 million.
Losers
- SmileDirectClub SDC shares fell 22.92% to $5.17 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 29.1 million shares, making up 502.87% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 billion. As per the news, the Q2 earnings report came out yesterday.
- Eyegate Pharmaceuticals EYEG shares fell 22.48% to $1.76. As of 12:30 EST, this security is trading at a volume of 4.7 million shares, making up 387.49% of its average full-day volume over the last 100 days. The company's market cap stands at $12.4 million.
- Reata Pharmaceuticals RETA stock fell 19.31% to $98.55. The current volume of 1.4 million shares is 319.4% of Reata Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.5 billion. The company's, Q2 earnings came out yesterday.
- ZIOPHARM Oncology ZIOP stock fell 18.86% to $1.86. As of 12:30 EST, ZIOPHARM Oncology's stock is trading at a volume of 3.3 million, which is 203.23% of its average full-day volume over the last 100 days. The company's market cap stands at $400.5 million. As per the press release, Q2 earnings came out yesterday.
- Talkspace TALK shares decreased by 18.76% to $4.82. Talkspace's stock is trading at a volume of 2.4 million shares as of 12:30 EST. This is 284.67% of its average full-day volume over the last 100 days. The company's market cap stands at $733.5 million. As per the news, the Q2 earnings report came out yesterday.
- Catabasis Pharmaceuticals CATB stock declined by 16.99% to $1.29. The current volume of 1.0 million shares is 93.42% of Catabasis Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $99.6 million. As per the news, the Q2 earnings report came out yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in